Expression of HIF-1 alpha in medullary thyroid cancer identifies a subgroup with poor prognosis

Author(s):
Lodewijk, L.; Diest, P. van; Groep, P. van der; Hoeve, N. ter; Schepers, A.; Morreau, J. (0000-0003-0140-443X); Bonenkamp, J.; Engen-van Grunsven, A. van; Kruijff, S.; Hemel, B. van; Links, T.; Dijkum, E.N. van; Eeden, S. van; Valk, G.; Rinkes, I.B.; Vriens, M.
Published
2017
Publication type
Article / Letter to editor
medullary thyroid cancerhypoxia inducible factor 1 alphaimmunohistochemistrytissue microarrayoncology
Date issued
2017-04-25
Language
English
Is part of
Oncotarget (2017), Vol. 8, no. 17, p. 28650-28659
hdl
1887/116287
doi
10.18632/oncotarget.15622